Johnson & Johnson Proposes $5.5B Settlement for Baby Powder Lawsuits

JNJ0.29%
Key Takeaways
  • Johnson & Johnson proposed a $5.5 billion settlement to resolve approximately 76,000 talc-related lawsuits on the 28th.
  • The company plans to pay up to $3 billion initially in 2027, with remaining compensation distributed after 2028.
  • Johnson & Johnson discontinued talc baby powder sales in North America in 2020 and globally in 2023.

Johnson & Johnson proposed a settlement of up to $5.5 billion to resolve tens of thousands of US lawsuits alleging its baby powder products caused ovarian cancer, according to CNN reporting on the 28th (US local time). The pharmaceutical company plans to pay up to $3 billion initially in 2027, with remaining compensation distributed after 2028. The proposal addresses approximately 76,000 claims and requires approval from law firms representing at least 95% of claimants to take effect, as J&J seeks to end years of litigation over allegations that its talc-based products contained asbestos.

Johnson & Johnson Proposes $5.5 Billion Settlement Structure

The settlement proposal covers approximately 76,000 claims filed against Johnson & Johnson. Under the payment plan, the company will distribute up to $3 billion in 2027 as an initial payment, with the remaining compensation scheduled for disbursement after 2028. The agreement requires consent from law firms representing at least 95% of all claimants before it can be finalized.

Company Faces 76,000 Talc-Related Claims

Johnson & Johnson has faced litigation for years over allegations that its baby powder products contained asbestos in the talc ingredient, which plaintiffs claim caused ovarian cancer. The company has consistently denied these allegations and maintained the safety of its products throughout the legal proceedings.

J&J Discontinued Talc Baby Powder Sales Globally

In 2020, Johnson & Johnson stopped selling talc-based baby powder in North America and switched to cornstarch-based products. The company extended this measure to global markets in 2023, discontinuing talc baby powder sales worldwide.

Federal Judge and Jury Issue Contrasting Rulings

Last week, a federal judge ruled that plaintiffs must present evidence demonstrating a specific link between ovarian cancer development and Johnson & Johnson's talc products. In contrast, a Los Angeles jury in October awarded $966 million to the family of a woman who died from mesothelioma allegedly caused by asbestos exposure. Johnson & Johnson stated it plans to appeal that verdict.

FAQ

What settlement amount did Johnson & Johnson propose for talc lawsuits? Johnson & Johnson proposed a settlement of up to $5.5 billion to resolve approximately 76,000 claims alleging its baby powder products caused ovarian cancer. The company plans to pay up to $3 billion in 2027, with remaining compensation distributed after 2028.

Why did Johnson & Johnson stop selling talc-based baby powder? Johnson & Johnson discontinued talc-based baby powder sales in North America in 2020 and globally in 2023, switching to cornstarch-based products. This decision came after years of litigation over allegations that the talc ingredient contained asbestos, though the company has consistently denied these claims and maintained product safety.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments